Immutep
IMMP
$2.96
Share price
1.37%
Change (1 day)
12.98%
Change (1 year)
Categories
Market capitalization of Immutep (IMMP)
Market cap: $0.35 Billion
As of May 2024 Immutep has a market cap of $0.35 Billion. This makes Immutep the world's 6403th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Immutep from 2009 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.35 B | 23.33% |
| 2023 | $0.28 B | 74.94% |
| 2022 | $0.16 B | -38.63% |
| 2021 | $0.26 B | 28.54% |
| 2020 | $0.20 B | 192.13% |
| 2019 | $70.76 M | 7.29% |
| 2018 | $65.96 M | 62.83% |
| 2017 | $40.51 M | -24.9% |
| 2016 | $53.94 M | -29.42% |
| 2015 | $76.43 M | 105.96% |
| 2014 | $37.1 M | -13.17% |
| 2013 | $42.73 M | -64.92% |
| 2012 | $0.12 B | -23.44% |
| 2011 | $0.15 B | |
| 2009 | $56.67 M |
End of Day market cap according to different sources
On May 17th, 2024 the market cap of Immutep was reported to be:
$0.35 Billion
$0.35 Billion
$3.51 Billion
$0.35 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Illumina ILMN | $17.69 B | 4,928.07% | 🇺🇸 USA |
 FibroGen FGEN | $0.11 B | -66.08% | 🇺🇸 USA |
 HTG Molecular Diagnostics
HTGM | $1.06 M | -99.70% | 🇺🇸 USA |